Protein
|
HLA
|
HIV polymorphisma
|
Early infection
|
Chronic infection
|
CD8+ epitope*
|
p-value (early vs. chronic)d
|
---|
Odds Ratiob
|
p-valuec
|
Odds Ratiob
|
p-valuec
|
(HIV codon coordinates)
|
---|
Gag
|
B*57:01
|
T242N
|
33
|
3 × 10-9
|
151
|
6 × 10-17
|
TSTLQEQIGW (240-248)
|
0.3
|
|
C*07:04
|
M378x
|
3.6
|
0.006
|
3.5
|
0.0002
|
IMMQRGNF (377-383)*
|
0.7
|
|
A*31:01
|
K397R
|
6.2
|
1 × 10-7
|
83
|
8 × 10-10
|
CGKEGHIAR (395–403)
|
0.5
|
|
A*31:01
|
I401L
|
5.1
|
0.005
|
1.98
|
0.01
|
CGKEGHIAR (395–403)
|
0.2
|
|
A*31:01
|
R403K
|
1.5
|
0.007
|
~41
|
1 × 10-7
|
CGKEGHIAR (395–403)
|
0.002
|
Pol (RT)
|
B*51:01
|
I135x
|
2.1
|
0.004
|
25
|
5 × 10-11
|
TAFTIPSI (128–135)
|
0.0001
|
Pol (Int)
|
B*51:01
|
L28I
|
16
|
0.009
|
5
|
7 × 10-5
|
LPPIVAKEI (28–36)
|
0.2
|
Nef
|
B*37:01
|
E38
D
|
13
|
0.006
|
~24
|
0.002
|
LEKHGAIT (37–45)*
|
0.2
|
|
C*03:04
|
V85L
|
2.4
|
0.002
|
4
|
0.0002
|
AALDLSHFL (83–91)
|
0.6
|
|
A*11:01
|
K92R
|
5.3
|
0.009
|
8.4
|
4 × 10-6
|
AVDLSHFLK (84–92)
|
0.2
|
|
C*03:04
|
H102x
|
3.2
|
0.001
|
~1
|
0.25
|
none
|
0.1
|
|
A*23:01
|
F143Y
|
8.4
|
0.01
|
852
|
5 × 10-8
|
RYPLTFGWCF (134–143)
|
0.1
|
|
B*57:01
|
x133I
|
6
|
0.004
|
1.4
|
0.29
|
YTPGPGIRY (127–135)
|
0.2
|
|
A*24:02
|
Y135F
|
2.3
|
0.004
|
15
|
2 × 10-21
|
RYPLTFGW (134–141)
|
0.0005
|
- aA total of 24 associations, occurring at 14 unique HIV-1 codons, are listed. The total 24 is reached because HLA-associated nonadapted and adapted forms are counted individually (e.g. B*57:01-Gag-T242N comprises two associations– the nonadapted T and the adapted N). Cases where a specific non-adapted or adapted form was not detected in early infection are denoted by a lowercase “x” (e.g. B*51:01-RT-I135x). Polymorphisms in bold represent associations detectable in both early and chronic infection at p ≤ 0.01; those italicized represent associations detectable in only the early cohort with p < 0.01.
- bWhere both nonadapted and adapted forms for a given HLA are identified, the maximum absolute Odds Ratio is shown.
- cWhere both nonadapted and adapted forms for a given HLA are identified, the lowest p-value is shown. Note the chronic p-value for B*37:01-Nef-E38D refers to its nonadapted (E38x) form; the p-value for the adapted (x38D) form at this stage is 0.07.
- *Bioinformatically predicted CTL epitopes are denoted by asterisks (*); the remainder are published (http://www.hiv.lanl.gov/content/immunology/tables/tables.html). Bold letters indicate the position within the epitope where the HLA-associated polymorphism occurs. Note the C*03-restricted AALDLSHFL epitope has been published in its C*03-adapted form.
- dFor each HLA-associated polymorphism in the table, its strength association in early versus chronic infection was compared using a previously-described phylogenetically-corrected interaction test (see Methods and [12],[27]). The p-values of these comparisons are listed in this column.